Toggle light / dark theme

Alfred G. Knudson Jr., a medical researcher who helped decode a mystery of cancer — using genetics, mathematics and intuition to explain how and why certain forms of the disease attack — died July 10 at his home in Philadelphia. He was 93.

His death was announced by the Fox Chase Cancer Center in Philadelphia, where Dr. Knudson had served as president, scientific director and in other capacities since joining the institution in 1976. He had heart ailments and dementia, said his wife, Anna Meadows, a pediatric oncologist.

Dr. Knudson was among the most renowned researchers in his field, with honors including a 1998 Lasker Award, commonly known as the American Nobel, and a 2004 Kyoto Prize recognizing him for a discovery that “opened a new horizon in modern cancer genetics and played a pivotal role in the major developments” in cancer research.

Read more

Imagine your chest tightening as you struggle for for breath. There’s no cure for it, and it will most likely be a hindrance to your day-to-day life.

This feeling is familiar to the 300 million people worldwide who suffer from asthma. In the US alone, one in 14 people has asthma, and ten of them die from asthma every day.

For children, relying on symptoms to determine whether an asthma attack is about to happen is particularly difficult. Not only is it harder for them to articulate their discomfort, it’s less likely that they will be able to attribute it to asthmatic symptoms.

Read more

When we look at the huge tech and industrial revolution that is just on the verge of happening due to QC and Medical technologies; synthetic diamonds will be a central piece of this story. I hope Intel, Nvidia, HP, Xerox, Apple, etc. all are assessing how they can either produce or partner with producers of synthetic diamonds. Printer companies could be big players in the mass production story of Synthetic Diamonds; and partnerships between Intel and HP or Intel and Xerox could prove to be fruitful.


COULD synthetic diamonds be key to developing the advanced electronics of tomorrow? A company crowd-funding on Cambridge’s SyndicateRoom thinks so.

Evince is looking to raise £650,000 to develop a working prototype of its new semi-conductor, which it says has the potential to perform 100 times better than silicon.

The company’s patented system combines advanced semiconductor and vacuum microelectronics concepts to create its platform technology.

Roger Dumoulin-White, president and CEO of Theralase Technologies, explains his company’s two divisions: the currently operating therapeutic laser division and the anti-cancer division. The company’s TLC-1000 laser is used for pain relief, tissue healing and more, and upwards of 1,200 medicial facilities worldwide use the device. The next-generation TLC-2000 laser was recently FDA-approved. At this time, Theralase Technologies is conducting clinical trials for photodynamic compounds that help to destroy cancer cells.

Click play to learn how these new technologies have the potential to revolutionize cancer treatment.

Entrepreneur Network is a premium video network providing entertainment, education and inspiration from successful entrepreneurs and thought leaders. We provide expertise and opportunities to accelerate brand growth and effectively monetize video and audio content distributed across all digital platforms for the business genre.

Read more

At the National Institute of Biomedical Imaging and Bioengineering (NIBIB) and Tufts University a team has developed a microfluidic chip that mimics human tissue for use in drug testing applications. The chip is based on a silk gel that overcomes the limitations of polydimethylsiloxane (PDMS), a silicon material widely used to host living cells within microfluidic devices. As an example, PDMS has problems handling lipids, absorbing them instead of letting them move freely along with other nearby compounds and so not applicable with lipid-based compounds. Additionally, PDMS is not biodegradable and so a small device based on it can’t easily be used as an implantable. Silk, on the other hand, just needed a bit of engineering to make a candidate that overcomes many of PDMS’s limitations.

Read more

IRVINE, Calif., July 11, 2016 /PRNewswire/ — From measuring glaucoma to augmenting reality, advances in technology have enabled smart contact lenses to steadily gain traction in the past year. Although still in the early stages of development, the introduction of such novelties will inevitably be life-changing.

Photo — http://photos.prnewswire.com/prnh/20160711/388295

Read more

Interesting.


WHAT: Scientists at the National Institutes of Health are reporting new, unexpected details about the fundamental structure of collagen, the most abundant protein in the human body. In lab experiments, they demonstrated that collagen, once viewed as inert, forms structures that regulate how certain enzymes break down and remodel body tissue. The finding of this regulatory system provides a molecular view of the potential role of physical forces at work in heart disease, cancer, arthritis, and other disease-related processes, they say. The study appears in the current online issue of the Proceedings of the National Academy of Sciences.

Scientists have known for years that collagen remodeling plays an important role in a wide variety of biological processes ranging from wound healing to cancer growth. In particular, researchers know that collagen is broken down by a certain class of enzymes called matrix metalloproteinases (MMPs), but exactly how they did this remained somewhat of a mystery, until now.

In the NIH study, the scientists isolated individual, nano-sized collagen fibrils from rat-tail tendons. They then exposed the collagen fibrils to fluorescently-labeled human MMP enzymes. Using video microscopy, the scientists tracked thousands of enzymes moving along a fibril. Unexpectedly, the scientists observed that the enzymes preferred to attach at certain sites along the fibril, and over time these attachment sites slowly moved, or disappeared and reappeared in other positions. These observations revealed collagen fibrils have defects that spontaneously form and heal. In the presence of tension, such as when tendons stretch, defects are likely eliminated, preventing enzymes from breaking down collagen that is loaded by physical force, the researchers suggest. In short, they identified a possible strain-sensitive mechanism for regulating tissue remodeling.

Read more

Imagine a couple wanting to have a baby. They see the fertility specialist at a clinic, provide genetic material such as sperm or skin cells, and return sometime later. ‘The DNA of the resulting embryos will then be sequenced and carefully analyzed before decisions are made about which embryo or embryos to transfer to a womb for possible development,’ Greely writes. ‘Prospective parents will be told as much as they wish to know about the genetic makeup of dozens of embryos, and they will pick one or two for implantation, gestation, and birth.’ Besides the advantages of eliminating certain diseases, ‘It will be safe, lawful, and free.’


Will we be building a better world or a more homogeneous one?

Read more